Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

185 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma trial results

Recruiting

Pancreatic Cancer Detection Consortium

NCT06388967

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Translational Genomics Research Institute Phoenix, Arizona, United States
  • Honorhealth Scottsdale, Arizona, United States
  • City of Hope Medical Center Monrovia, California, United States
  • Hoag Center Newport Beach, California, United States
View Trial Details
Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NCT05482893

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute (SCRI) Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

NCT06562192

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +26 more
Locations
  • Uni of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California LA Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 29 locations
View Trial Details
Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

NCT06710756

Conditions
Adenoma, Adnexal Diseases, Colonic Diseases, +39 more
Locations
  • University of Miami Miami, Florida, United States
  • Biogenix Miami, Florida, United States
  • University of Kansas Kansas City, Kansas, United States
  • University of Kentucky Lexington, Kentucky, United States
View Trial Details
Recruiting

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

NCT07261631

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +30 more
Locations
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Odense C, Denmark
  • Novartis Investigative Site Vandœuvre-lès-Nancy, France
  • Novartis Investigative Site Essen, Germany
View Trial Details

Related conditions